Welcome to our dedicated page for Adamas Trust SEC filings (Ticker: ADAMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Adamas Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Adamas Trust's regulatory disclosures and financial reporting.
Norcutt Steven G reported acquisition or exercise transactions in this Form 4 filing.
ADAMAS TRUST, INC. director Steven G. Norcutt received a grant of deferred stock units as equity compensation. He was awarded 14,238 deferred stock units that may be settled one-for-one in common shares. These units vest immediately before the issuer’s next annual stockholder meeting in the following calendar year, provided he continues serving the company until that date. After this grant, he holds 51,378 deferred stock units in total. Settlement of the vested units has been deferred until the date of a Change in Control, as defined in the company’s 2017 Equity Incentive Plan.
Greenberg Audrey reported acquisition or exercise transactions in this Form 4 filing.
ADAMAS TRUST, INC. director Audrey Greenberg received an award of 14,238 deferred stock units (DSUs) as director compensation. These DSUs are granted under the Adamas Trust, Inc. 2017 Equity Incentive Plan and can be settled one-for-one into shares of common stock.
The DSUs will vest on the day immediately before the company’s next annual stockholders’ meeting held in the following calendar year, provided she continues serving the company. Settlement of vested DSUs is deferred until a change in control or the third anniversary of the grant. Following this grant, she holds 51,378 DSUs.
Pendergast Lisa A reported acquisition or exercise transactions in this Form 4 filing.
ADAMAS TRUST, INC. director Lisa A. Pendergast received a grant of 14,238 Deferred Stock Units (DSUs) under the company’s 2017 Equity Incentive Plan. Each DSU is payable in one share of common stock.
The DSUs vest on the day immediately before the company’s next annual stockholder meeting in the following calendar year, provided she continues serving the company through that date. After this award, she holds 51,378 DSUs. Settlement of the vested DSUs has been deferred until a Change in Control as defined in the plan.
Clement Michael B. reported acquisition or exercise transactions in this Form 4 filing.
ADAMAS TRUST, INC. director Michael B. Clement received an award of 14,238 Deferred Stock Units (DSUs) as compensation. Each DSU is tied to one share of common stock and was granted at a price of $0.00 per unit.
The DSUs were granted under the Adamas Trust, Inc. 2017 Equity Incentive Plan and will vest on the day immediately before the company’s next annual stockholders’ meeting in the following calendar year, provided he continues to provide services through that date. After this grant, he holds 14,238 DSUs directly.
Cheng Gena reported acquisition or exercise transactions in this Form 4 filing.
Adamas Trust, Inc. reported that director Gena Cheng received a grant of 14,238 Deferred Stock Units (DSUs) as compensation. Each DSU may be settled on a one-for-one basis in common stock. After this award, Cheng holds 51,378 DSUs directly.
The DSUs will vest on the day immediately before the company’s next annual stockholders’ meeting in the following calendar year, provided Cheng continues to serve the company through that date. Settlement of the vested DSUs has been deferred until the date of a Change in Control as defined in the company’s 2017 Equity Incentive Plan.
Mumma Steven R reported acquisition or exercise transactions in this Form 4 filing.
Adamas Trust, Inc. director Steven R. Mumma received an award of 14,238 Deferred Stock Units (DSUs) as compensation. The DSUs were granted at no cash cost under the company’s 2017 Equity Incentive Plan and are each linked to one share of common stock.
The DSUs will vest on the day immediately before the company’s next annual stockholder meeting in the following calendar year, provided he continues to serve the company through that date. Settlement of the vested DSUs has been deferred until a Change in Control, and following this grant he holds 51,378 DSUs in total.
ADAMAS TRUST, INC. director Michael B. Clement exercised deferred stock units into common stock as part of his equity compensation. On June 10, 2026, he converted 18,678 deferred stock units into common shares at an exercise price of $0.00 per share.
Following this transaction, Clement directly holds 101,309 shares of common stock. The deferred stock units were originally granted on June 12, 2025 under the company’s 2017 Equity Incentive Plan and vested on June 10, 2026, the day before the 2026 annual stockholders meeting. This is a compensation-related exercise, not an open-market purchase or sale.
Adamas Trust, Inc. entered into an equity distribution agreement establishing an at-the-market common stock offering program of up to $250,000,000 in aggregate. The company may sell shares from time to time through JonesTrading, BTIG, and B. Riley Securities as sales agents, or directly to an agent acting as principal.
The agents may receive up to 2.0% of gross proceeds as compensation. Adamas Trust plans to use any net proceeds for general corporate purposes, including acquiring targeted mortgage-, residential housing- and credit-related assets and for working capital. The shares will be issued under its existing Form S-3 shelf registration, supported by a new prospectus supplement dated June 12, 2026.
Adamas Trust, Inc. filed a prospectus supplement establishing an at-the-market equity offering to sell up to $250,000,000 of its common stock under an equity distribution agreement with JonesTrading Institutional Services LLC, BTIG, LLC and B. Riley Securities, Inc. dated June 12, 2026. Sales may occur on Nasdaq or otherwise as an at-the-market program, at prevailing market or negotiated prices, and Agents may purchase shares as principals under separate agreements. Agents may earn up to 2.0% of gross proceeds as compensation. The company states net proceeds will be used for general corporate purposes, including acquiring mortgage-, residential housing- and credit-related assets and working capital. The prospectus supplement notes ownership transfer limits (generally 9.9%) designed to preserve REIT qualification and discloses a last reported sale price of $9.11 per share on Nasdaq on June 11, 2026.
Adamas Trust, Inc. reported 2026 annual meeting results, compensation changes and new dividends. Stockholders approved a Third Amendment to the 2017 Equity Incentive Plan, adding 9,000,000 common shares for awards, raising the annual non-employee director compensation cap to $750,000 and extending the plan to April 23, 2036.
The Board adopted a nonqualified Deferred Compensation Plan and a 2024 PSU deferral election form for executives and directors. All seven director nominees were elected, say-on-pay passed, and Grant Thornton LLP was ratified as auditor. The Board declared a $0.27 per-share common dividend payable July 28, 2026 and quarterly dividends on Series D, E, F and G preferred stock for the period from April 15, 2026 to July 14, 2026.